Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry.

[1]  B. Reid,et al.  Barrett's esophagus and esophageal adenocarcinoma. , 1991, Gastroenterology clinics of North America.

[2]  Carissa A. Sanchez,et al.  17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma. , 1991, Cancer research.

[3]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[4]  A. Levine,et al.  The p53 tumour suppressor gene , 1991, Nature.

[5]  J. Marks,et al.  Genetic basis for p53 overexpression in human breast cancer. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Haggitt,et al.  Cancer surveillance in ulcerative colitis. , 1991, Gastroenterology.

[7]  T. Crook,et al.  p53 point mutation in HPV negative human cervical carcinoma cell lines. , 1991, Oncogene.

[8]  B. Reid,et al.  Endoscopic biopsy technique for acquiring larger mucosal samples. , 1991, Gastrointestinal endoscopy.

[9]  R. A. Metcalf,et al.  Mutational hot spot in the p53 gene in human hepatocellular carcinomas , 1991, Nature.

[10]  J. Wands,et al.  Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa , 1991, Nature.

[11]  C. Purdie,et al.  p53 expression in colorectal tumors. , 1991, The American journal of pathology.

[12]  J. Fraumeni,et al.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.

[13]  W. J. Brammar,et al.  Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas. , 1991, Oncogene.

[14]  B. Vogelstein,et al.  Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[15]  B. Vogelstein,et al.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. , 1990, Cancer research.

[16]  R Montesano,et al.  Frequent mutation of the p53 gene in human esophageal cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[18]  J. Bartek,et al.  Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro , 1990, International journal of cancer.

[19]  W. Bodmer,et al.  p53 mutations in colorectal cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Jeng-Shin Lee,et al.  Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Mane,et al.  Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products. , 1990, Cancer research.

[22]  J. Bartek,et al.  Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. , 1990, Oncogene.

[23]  A. Harris,et al.  Increased expression of mutant forms of p53 oncogene in primary lung cancer , 1990, The Lancet.

[24]  G. Thomas,et al.  Simultaneous monitoring of P53 protein and dna content of colorectal adenocarcinomas by flow cytometry , 1990, International journal of cancer.

[25]  J. Minna,et al.  Dominant oncogenes and tumor suppressor genes in the pathogenesis of lung cancer. , 1990, American journal of respiratory cell and molecular biology.

[26]  A. Levine.  Tumor suppressor genes , 1990, BioEssays : news and reviews in molecular, cellular and developmental biology.

[27]  F. Collins,et al.  Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.

[28]  J. Minna,et al.  p53: a frequent target for genetic abnormalities in lung cancer. , 1989, Science.

[29]  J. Trent,et al.  Chromosomal rearrangements in Barrett's esophagus. A premalignant lesion of esophageal adenocarcinoma. , 1989, Cancer genetics and cytogenetics.

[30]  D. Ledbetter,et al.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.

[31]  A. Tigges,et al.  Expression of the nuclear oncogene p53 in colon tumours , 1989, The Journal of pathology.

[32]  B. Reid,et al.  Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[33]  B. Reid,et al.  Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium. , 1989, Gastroenterology.

[34]  Overton Wr,et al.  Modified histogram subtraction technique for analysis of flow cytometry data , 1988 .

[35]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[36]  J. Mayberry,et al.  Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus , 1988, The British journal of surgery.

[37]  S. Davis,et al.  Incidence of cancer of the esophagus in the US by histologic type , 1988, Cancer.

[38]  G Van Belle,et al.  Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.

[39]  B. Reid,et al.  Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. , 1987, Gastroenterology.

[40]  S. Spechler.  Endoscopic surveillance for patients with Barrett esophagus: does the cancer risk justify the practice? , 1987, Annals of internal medicine.

[41]  M. Isobe,et al.  Localization of gene for human p53 tumour antigen to band 17p13 , 1986, Nature.

[42]  W G Doos,et al.  Adenocarcinoma and Barrett's esophagus. An overrated risk? , 1984, Gastroenterology.

[43]  A. Levine,et al.  Growth regulation of a cellular tumour antigen, p53, in nontransformed cells , 1984, Nature.

[44]  D. Skinner,et al.  Barrett's Esophagus: Comparison of Benign and Malignant Cases , 1983, Annals of surgery.

[45]  M. Bains,et al.  Adenocarcinoma in Barrett's esophagus. , 1983, The Journal of thoracic and cardiovascular surgery.

[46]  L. Johnson,et al.  Barrett's esophagus: a review. , 1983, The American journal of medicine.

[47]  D. Lane,et al.  T antigen is bound to a host protein in SY40-transformed cells , 1979, Nature.

[48]  D. Lane,et al.  p53: oncogene or anti-oncogene? , 1990, Genes & development.

[49]  B. Reid,et al.  Progression to cancer in Barrett's esophagus is associated with genomic instability. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[50]  B. Reid,et al.  Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. , 1988, Gastroenterology.

[51]  B. Reid,et al.  Barrett's esophagus and adenocarcinoma. , 1987, Annual review of medicine.

[52]  D. Givol,et al.  The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[53]  G. Nardi,et al.  The esophagus : medical and surgical management , 1958 .